Skip to main content
. 2020 May 8;21(9):3346. doi: 10.3390/ijms21093346

Table 1.

Variants identified by next generation sequencing (NGS).

PT-ID a Gene Name cDNA Change Protein Change dbSNP ID b ACMG Classification Global MAF c Population MAF d SIFT Score Polyphen Score Mutation Taster Pred CADD
ALS literature
ALS_78 ALS2 c.1115C > G p.Pro372Arg rs190369242 3 0.00130 0.00220 0.64 (T) 0.919 (D) 0.683 (D) 19.65
ALS_6 OPTN c.941A > T p.Gln314Leu rs142812715 3 0.00017 0.00030 0.01 (D) 0.999 (D) 0.993 (D) 27.70
ALS_56 SETX c.654G > C p.Lys218Asn rs117861188 3 0.00033 0.00060 0.0 (D) 0.961 (D) 0.900 (D) 23.80
ALS_34 SOD1 c.203T > C p.Leu68Pro CM110553 5 0.00000 0.00000 0.21 (T) 0.001 (B) 0.99 (N) 6.15
ALS_6 SOD1 c.217G > A p.Gly73Ser rs121912455 5 0.00000 0.00000 0.0 (D) 0.970 (D) 0.999 (D) 29.30
ALS_23 TBK1 c.1190T > C p.Ile397Thr rs755069538 5 0.00010 0.00030 0.31 (T) 0.039 (B) 0.999 (D) 22.80
ALS and non-ALS literature
ALS_5 SETX c.59G > A p.Arg20His rs79740039 3 0.00683 0.01051 0.25 (T) 0.001 (B) 0.999 (N) 3.43
ALS_18 SETX c.59G > A p.Arg20His
ALS_60 SETX c.59G > A p.Arg20His
ALS_4 SPG11 c.1348A > G p.Ile450Val rs3759873 1 0.01672 0.00450 0.78 (T) 0 (B) 0.994 (D) 6.31
ALS_30 SPG11 c.3037A > G p.Lys1013Glu rs111347025 2 0.00861 0.01448 0.73 (T) 0.002 (B) 0.963 (D) 22.70
ALS_43 SPG11 c.3037A > G p.Lys1013Glu
ALS_32 SPG11 c.6224A > G p.Asn2075Ser rs140824939 3 0.00310 0.00489 0.49 (T) 0 (B) 0.999 (N) 0.28
Non-ALS literature
ALS_2 BSCL2 c.844G > A p.Ala282Thr(218)§ rs190842600 3 0.00022 0.00000 0.08 (T) 1 (D) 0.999 (D) 25.90
ALS_53 BSCL2 c.1033C > T p.Arg345Trp(281)§ rs767820877 3 0.00000 0.00000 0.02(D) 0.987 (D) 0.999 (D) 21.40
ALS_41 HSPB3 c.347G > C p.Arg116Pro rs150931007 4 0.00011 0.00010 0 (D) 1 (D) 0.999 (D) 29.70
ALS_1 MFN2 c.1574A > G p.Asn525Ser rs145654854 3 0.00017 0.00021 1 (T) 0 (B) 0.753 (N) 19.62
ALS_6 SETX c.4612C > T p.Arg1538Trp rs147018359 3 0.00000 0.00000 0.21 (T) 0 (B) 0.999 (N) 17.31
ALS_29 SETX c.4612C > T p.Arg1538Trp
ALS_30 SPG11 c.5986_5987insT p.Cys1996Leufs*4 rs312262775 5 0.00002 0.00000 - - - -
ALS_7 SQSTM1 c.352C > T p.Pro118Ser rs200152247 3 0.00006 0.00010 0.54 (T) 0.009 (B) 0.999 (D) 20.90
ALS_34 SQSTM1 c.802C > G p.Leu268Val rs753685955 3 0.00001 0.00000 1 (T) 0.004 (B) 0.824 (N) 17.73
Variants present only in population databases
ALS_64 BSCL2 c.689G > A p.Ser230Asn (166) § rs778378228 4 0.00001 0.00000 0.11 (T) 0.820 (P) 0.824 (N) 23.40
ALS_67 BSCL2 c.785C > T p.Ala262Val(198) § rs140896339 3 0.00028 0.00000 0.50 (T) 0.085(B) 0.999 (N) 18.85
ALS_7 BSCL2 c.1057T > A p.Ser353Thr(189) § rs769769807 3 0.00001 0.00000 0.17 (T) 0.006 (B) 0.999 (N) 6.03
ALS_69 BSCL2 c.1282C > T p.Pro428Ser(364) § rs369732238 3 0.00006 0.00010 0.1 (T) 0.573 (P) 0.905 (N) 18.59
ALS_43 BSCL2 c.1300T > C p.Ser434Pro(370) § rs199584887 3 0.00006 0.00000 0.44 (T) 0.001 (B) 0.999 (N) 1.58
ALS_52 DCTN1 c.1486G > C p.Val496Leu rs773897036 4 0.00002 0.00000 0.06 (T) 0.984 (D) 0.999 (D) 23.50
ALS_13 DYNC1H1 c.265G > A p.Gly89Ser rs749973847 3 0.00002 0.00000 0.74 (T) 0.019 (B) 0.999 (D) 22.80
ALS_40 DYNC1H1 c.3748G > A p.Val1250Met rs369914512 3 0.00006 0.00010 0.07 (T) 0.978 (D) 0.999 (D) 29.20
ALS_41 DYNC1H1 c.12213C > T # p.Ile4071Ile rs746950373 3 0.00002 0.00000 0.48 (T) - 1 (D) 12.50
ALS_33 HSPB1 c.403T > G p.Ser135Ala rs766728475 4 0.00002 0.00000 0.07 (T) 0.623 (P) 0.999 (D) 25.40
ALS_53 HSPB3 c.199G > A p.Gly67Ser rs35258119 3 0.00727 0.00000 0.2 (T) 0.036 (B) 0.999 (N) 17.28
ALS_4 HSPB3 c.346C > T p.Arg116X rs757339596 4 0.00003 0.00000 - - 0.999 (D) 11.58
ALS_58 PLEKHG5 c.3049G > A p.Gly1017Arg rs755699992 3 0.00000 0.00000 0.56 (T) 0.047 (B) 0.999 (N) 0.16
ALS_15 SETX c.3182C > T p.Pro1061Leu rs12352982 3 0.01604 0.00000 1 (T) 0 (B) 0.999 (N) 0.90
ALS_46 SETX c.7435A > G p.Ile2479Val rs536912256 3 0.00006 0.00000 0.43 (T) 0.001 (B) 0.999 (N) 0.76
ALS_73 SPG11 c.1675T > A p.Ser559Thr rs773680273 3 0.00001 0.00000 0.2 (T) 0.990 (D) 0.591 (D) 20.80
ALS_27 SPG11 c.2764G > A p.Val922Ile rs139399250 3 0,00006 0,00010 0.43 (T) 0.002(B) 0.999 (N) 2.25
ALS_67 SPG11 c.6201A > T # p.Gly2067Gly rs764991726 3 0,00001 0,00000 1 (T) - 0.987 (D) 7.48
Novel candidate ALS-associated variants
ALS_34 DYNC1H1 c.4183A > C p.Lys1395Gln - 4 - - 0.12 (T) 1.000 (D) 0.999 (D) 34.00
ALS_22 DYNC1H1 c.5303G > T p.Ser1768Ile - 3 - - 0.1 (T) 0.028 (B) 0.999 (N) 15.71
ALS_27 FIG4 c.1030C > A p.Pro344Thr - 4 - - 0.37 (T) 0.875 (P) 0.999 (D) 25.40
ALS_21 FUS c.1168 + 7A > G # - - 3 - - - - - -
ALS_40 SETX c.5852A > T p.His1951Leu - 4 - - 0.13 (T) 0.961 (D) 0.974 (D) 25.80
ALS_70 SPG11 c.4826delT p.Met1609Serfs*31 - 4 - - - - 1 (D) 8.99

a PT-ID, patient identification code; b dbSNP150; c Global MAF, global allele counts were calculated from all subjects in the ExAc database; d MAF population, population allele count refers to European Ancestry subjects from the ExAc database; §, the variants present in BSCL2 gene has been reported the positions in both isoform NM_001122955.3 and NM_001130702.2 in bracket; #, variants predicted as splice site by in silico tools; ACMG, American College of Medical Genetics and Genomics; ACMG classification: 1 = benign, 2 = likely benign, 3 = uncertain significance, 4 = likely pathogenic, 5 = pathogenic; MAF, minor allele frequency; SIFT: T = tolerated and D = deleterious; Polyphen: B = benign, P = possibly damaging, D = damaging; Mutation Taster: D = disease causing, N = polymorphism, A = disease causing automatic; CADD, combined annotation dependent depletion; CADD scores, scaled CADD scores (Phred like) for scoring deleteriousness. Variants in common between ALS patients and controls were excluded (Table S4).